Age, Biography and Wiki
John Hardy (John Anthony Hardy) was born on 9 November, 1954 in United Kingdom, is a Sir John Anthony Hardy is human geneticist. Discover John Hardy's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 69 years old?
| Popular As |
John Anthony Hardy |
| Occupation |
N/A |
| Age |
69 years old |
| Zodiac Sign |
Scorpio |
| Born |
9 November 1954 |
| Birthday |
9 November |
| Birthplace |
United Kingdom |
| Nationality |
United Kingdom
|
We recommend you to check the complete list of Famous People born on 9 November.
He is a member of famous with the age 69 years old group.
John Hardy Height, Weight & Measurements
At 69 years old, John Hardy height not available right now. We will update John Hardy's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
John Hardy Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is John Hardy worth at the age of 69 years old? John Hardy’s income source is mostly from being a successful . He is from United Kingdom. We have estimated John Hardy's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
John Hardy Social Network
Timeline
Sir John Anthony Hardy (born 9 November 1954) is a human geneticist and molecular biologist at the Reta Lila Weston Institute of Neurological Studies at University College London with research interests in neurological diseases.
Hardy attended St Ambrose College in the late 1960s, where his interest in biochemistry was encouraged by his Biology teacher, Mrs Cox.
He received his Bachelor of Science degree from the University of Leeds in 1976 and his PhD from Imperial College London in 1981 for research on dopamine and amino acid neuropharmacology.
Following his PhD, Hardy did postdoctoral research at the MRC Neuropathogenesis Unit in Newcastle upon Tyne, England and then further postdoctoral work at the Swedish Brain Bank in Umeå, Sweden where he started to work on Alzheimer's disease.
He became Assistant Professor of Biochemistry at St. Mary's Hospital, Imperial College London in 1985 and initiated genetic studies of Alzheimer's disease there.
He became Associate Professor in 1989 and then took the Pfeiffer Endowed Chair of Alzheimer's Research at the University of South Florida, in Tampa in 1992.
Among other awards and honours, Hardy has won the Breakthrough Prize in Life Sciences for dissecting the causes of Alzheimer's disease, Parkinson's disease and frontotemporal dementia; the MetLife prize for research into Alzheimer's disease, and the Potamkin Prize for his work in describing the first genetic mutations in the amyloid gene in Alzheimer's disease, in 1991.
In 1996 he moved to Mayo Clinic in Jacksonville, Florida, as Consultant and Professor of Neuroscience.
He became Chair of Neuroscience in 2000 and moved to National Institute on Aging, Bethesda, Maryland, as Chief of the Laboratory of Neurogenetics in 2001.
In 2007 he took up the Chair of Molecular Biology of Neurological Disease at the Reta Lila Weston Institute of Neurological Studies, University College London.
He was elected a Fellow of the Royal Society (FRS) in 2009.
He was knighted in the 2022 New Year Honours for services to "human health in improving our understanding of dementia and neurodegenerative diseases".
On 29 November 2015, he was awarded the Breakthrough Prize.
In 2018, Hardy, along with Christian Haass, Bart De Strooper and Michel Goedert, received the Brain Prize for "groundbreaking research on the genetic and molecular basis of Alzheimer’s disease."
